Trials / Completed
CompletedNCT00862641
A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
A Phase 4, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD).
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,009 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to determine the safety and tolerance of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Regadenoson | IV |
| DRUG | Placebo | IV |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2009-03-17
- Last updated
- 2012-09-18
- Results posted
- 2010-12-15
Locations
48 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00862641. Inclusion in this directory is not an endorsement.